The trade body for the British pharmaceutical industry has issued a response to a report from the Journal of Royal Society of Medicine, which raised concerns ab 25 August 2023
In the latest reminder about the lingering presence of COVID-19, the US Department of Health and Human Services (HHS) has awarded more than $1.4 billion for Pro 23 August 2023
Across the globe, tense relationships between countries are on the rise. The PwC 25th Annual Global CEO Survey showed that 32% of executives cited geopolitical 17 August 2023
As European drugmakers wrestle with regional lawmakers over proposed legislative changes, the industry has been emboldened by a German government report raising 11 August 2023
Building on lessons learned during the coronavirus pandemic, the UK government is to open a major new vaccine research center aimed at combating future threats. 10 August 2023
Israeli biotech RedHill Biopharma has had its COVID-19 candidate RHB-107 accepted for inclusion in a US Government-funded project to test products for the outpa 31 July 2023
US healthcare conglomerate Johnson & Johnson and Japanese drugmaker Astellas have joined a growing list of companies and groups that are suing the US government 20 July 2023
Tense negotiations over the future of drug pricing in the UK are off to a rocky start, as the UK government seeks to sustain the high rebate rates in the curren 20 July 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.